PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer
Abstract Background Bioactive lipids involved in the progression of various diseases. Nevertheless, there is still a lack of biomarkers and relative regulatory targets. The lipidomic analysis of the samples from platinum-resistant in gastric cancer patients is expected to help us further improve our...
Main Authors: | Menglin Chen, Cancan Zhang, Huaizhi Li, Shanshan Zheng, Yaqi Li, Mengyun Yuan, Yuxuan Chen, Jian Wu, Qingmin Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-024-05055-4 |
Similar Items
-
DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer
by: Zhiyuan Fan, et al.
Published: (2023-01-01) -
The emerging role of glycolysis and immune evasion in gastric cancer
by: Shanshan Zheng, et al.
Published: (2023-12-01) -
RUNX2 Reverses p53-Induced Chemotherapy Resistance in Gastric Cancer
by: Huang Y, et al.
Published: (2023-03-01) -
Dehydrocostus lactone suppresses gastric cancer progression by targeting ACLY to inhibit fatty acid synthesis and autophagic flux
by: Yuxuan Chen, et al.
Published: (2025-01-01) -
Platinum preparations in the treatment of trophoblastic tumors
by: I. V. Markina, et al.
Published: (2014-08-01)